Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Freenome

Explore full profile

A health technology company developing accurate, accessible and non-invasive disease screening products

San Francisco, United StatesFounded 2014Biotech & Life Sciences
Valuation $1.28B Market cap · Aug/2026
Revenue $30M Latest reported FY

At a glance

Founded
2014
Headquarters
San Francisco, United States
Listing
Public via SPAC 2026
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierColt$25–100M revenue

Latest news

Press, funding announcements and product moves mentioning Freenome.

See all news

Investors

48 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed5 investors entered at this stage

Series A9 investors entered at this stage

Series B and later34 investors entered at this stage

  • Kaiser Permanente Ventures
  • EcoR1 Capital
  • T. Rowe Price
  • Quest Diagnostics
  • Logos Capital
  • Squarepoint Capital
  • Farallon Capital Management
  • Kaiser Permanente
  • Roche
  • ARK Invest
  • Roche Venture Fund
  • RA Capital Management
  • BrightEdge
  • Fidelity Investments
  • HBM Healthcare Investments
  • Rock Springs Capital
  • Pura Vida Investments
  • Eventide Asset Management
  • Sands Capital Management
  • Cormorant Capital
  • The Colon Cancer Alliance
  • Novartis
  • Cormorant Asset Management
  • ArrowMark Partners
  • Perceptive Advisors
  • Artis Ventures
  • Ridgeback Capital
  • Intermountain Ventures
  • Bain Capital Life Sciences
  • Suvretta Capital Management
  • Catalio Capital Management
  • Janus Henderson Investors
  • Byers Capital
  • Soleus Capital

Ownership

Share of equity by holder

Share of equity by holder, from Dealroom's shareholder data. Stakes as last recorded by Dealroom (2026).

32.5% Roche

See the full cap table on Dealroom →

Talent

Book a demo to see the people
Employees mapped 403 incl. 14 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 15 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 10 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

5 of 10 startups shown

Former Freenome employees who went on to found companies, sorted by Dealroom signal score.

DinariEst. 2021
Gabriel OtteUnited States
Signal score87
Modern IntelligenceEst. 2020
John DulinUnited States
Signal score81
Centauri TherapeuticsEst. 2014
Charles Campbell RobertsUnited Kingdom
Signal score77
ParcelBioEst. 2023
David WeinbergUnited States
Signal score76
CulminationEst. 2022
NMNickolas MarkUnited States
Signal score72
5 more alumni-founded companies in this previewBook a demo

Global footprint

Workforce and web traffic by country
Workforce by country
8 countries with
team presence
🇺🇸 United States96.2%
🇬🇧 United Kingdom1%
🇨🇦 Canada0.6%
🇨🇭 Switzerland0.6%
🇦🇹 Austria0.6%
Top 5 of 8 shown
Web traffic by country
20K monthly visits
across markets
🇺🇸 United States92.5%
🇬🇧 United Kingdom3.5%
🇮🇳 India2.5%
🇵🇭 Philippines0.5%
🇩🇪 Germany0.5%
Top 5 markets shown

Patents

Estimated portfolio value
$7M

21 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Freenome on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Freenome on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles